Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Nat Biotechnol. 2011 Jul 7;29(8):731–734. doi: 10.1038/nbt.1927

Table 1.

Summary of targeting experiments using TALENs OCT 4

correctly targeted clones
cell line
targeted
TALEN
pair
donor # of
clones
picked
random
integration
targeted +
additional
integration
heterozygous homozygous targeting
efficiency
[%]
WIBR#3 hESC OCT4 intron1 OCT4-SAeGFP# 1 68 6 0 62 0 91
C1 iPSC OCT4 intron1 OCT4-SAeGFP# 1 7 0 0 7 0 100
WIBR#3 hESC OCT4 intron1 OCT4-SAeGFP# 3 35 0 0 34 0 97
C1 iPSC OCT4 intron1 OCT4-SAeGFP# 3 5 0 0 5 0 100
WIBR#3 hESC OCT4 intron1 OCT4-eGFP exon1 fusion 12 4 0 8 0 67
C1 iPSC OCT4 intron1 OCT4-eGFP exon1 fusion 1 0 0 1 0 100
WIBR#3 hESC OCT4 STOP OCT4-eGFP PGK-Puro (C-term fusion) 48 42 1 5 0 10
C1 iPSC OCT4 STOP OCT4-eGFP PGK-Puro (C-term fusion) 48 45 3 0 0 0
WIBR#3 hESC OCT4 STOP OCT4-2A-eGFP PGK-Puro (C-term fusion) 48 44 1 3 0 6
C1 iPSC OCT4 STOP OCT4-2Ae-GFP PGK-Puro (C-term fusion) 48 46 1 1 0 2
WIBR#3 hESC OCT4 STOP OCT4-eGFP-2A-Puro (genetrap) 48 0 26 22 0 46
PPP1R12C
WIBR#3 hESC PPP1R12C PPP1R12C-SA-2A-Puro 96 4 35 34 21 57
WIBR#3 hESC PPP1R12C PPP1R12C-PGK-Puro 107 19 23 52 13 61
WIBR#3 hESC PPP1R12C PPP1R12C-CAGGS-eGFP 32 1 16 12 3 47
C1 iPSC PPP1R12C PPP1R12C-SA-2A-Puro 24 1 7 8 8 66
C1 iPSC PPP1R12C PPP1R12C-PGK-Puro 55 4 24 19 8 49
C1 iPSC PPP1R12C PPP1R12C-CAGGS-eGFP 23 1 12 5 5 43
WIBR#3 hESC PPP1R12C eHiFi PPP1R12C-SA-2A-Puro 22 4 5 14 3 77
C1 iPSC PPP1R12C eHiFi PPP1R12C-SA-2A-Puro 20 0 7 9 4 65
PITX3
WIBR#3 hESC PITX3 Exon 1 PITX3 eGFP FW 96 62 22 11 1 13
C1 iPSC PITX3 Exon 1 PITX3 eGFP FW 96 88 4 4 0 4
C1 iPSC PITX3 Exon 1 PITX3 eGFP BW 96 84 11 1 0 1
WIBR#3 hESC PITX3 STOP PITX3-eGFP C-term fusion 48 20 16 11 1 23
C1 iPSC PITX3 STOP PITX3-eGFP C-term fusion 48 32 7 9 0 19
WIBR#3 hESC PITX3 STOP PITX3-eGFP C-term 2A fusion 96 32 44 19 1 21
C1 iPSC PITX3 STOP PITX3-eGFP C-term 2A fusion 48 24 13 9 2 23